These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35857090)

  • 1. Eye movement indices as predictors of conversion to psychosis in individuals at clinical high risk.
    Zhang D; Xu L; Xie Y; Tang X; Hu Y; Liu X; Wu G; Qian Z; Tang Y; Liu Z; Chen T; Liu H; Zhang T; Wang J
    Eur Arch Psychiatry Clin Neurosci; 2023 Apr; 273(3):553-563. PubMed ID: 35857090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of COVID-19 pandemic on individuals at clinical high-risk for psychosis: Evidence from eye-tracking measures.
    Zhang D; Guo Q; Xu L; Liu X; Zhang T; Liu X; Chen H; Li G; Wang J
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Aug; 118():110578. PubMed ID: 35618148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saccadic eye movements in different dimensions of schizophrenia and in clinical high-risk state for psychosis.
    Obyedkov I; Skuhareuskaya M; Skugarevsky O; Obyedkov V; Buslauski P; Skuhareuskaya T; Waszkiewicz N
    BMC Psychiatry; 2019 Apr; 19(1):110. PubMed ID: 30961571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P300 as an index of transition to psychosis and of remission: Data from a clinical high risk for psychosis study and review of literature.
    Tang Y; Wang J; Zhang T; Xu L; Qian Z; Cui H; Tang X; Li H; Whitfield-Gabrieli S; Shenton ME; Seidman LJ; McCarley RW; Keshavan MS; Stone WS; Wang J; Niznikiewicz MA
    Schizophr Res; 2020 Dec; 226():74-83. PubMed ID: 30819593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auditory N100 amplitude deficits predict conversion to psychosis in the North American Prodrome Longitudinal Study (NAPLS-2) cohort.
    Duncan E; Roach BJ; Massa N; Hamilton HK; Bachman PM; Belger A; Carrion RE; Johannesen JK; Light GA; Niznikiewicz MA; Addington JM; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Tsuang M; Walker EF; Woods SW; Nasiri N; Mathalon DH
    Schizophr Res; 2022 Oct; 248():89-97. PubMed ID: 35994912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in inflammatory balance correlates with conversion to psychosis among individuals at clinical high-risk: A prospective cohort study.
    Zhang T; Zeng J; Wei Y; Ye J; Tang X; Xu L; Hu Y; Cui H; Xie Y; Tang Y; Liu X; Liu H; Chen T; Li C; Wang J
    Psychiatry Res; 2022 Dec; 318():114938. PubMed ID: 36334327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes.
    Cui H; Giuliano AJ; Zhang T; Xu L; Wei Y; Tang Y; Qian Z; Stone LM; Li H; Whitfield-Gabrieli S; Niznikiewicz M; Keshavan MS; Shenton ME; Wang J; Stone WS
    Schizophr Res; 2020 Dec; 226():138-146. PubMed ID: 32694037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.
    Seidman LJ; Giuliano AJ; Meyer EC; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Bearden CE; Christensen BK; Hawkins K; Heaton R; Keefe RS; Heinssen R; Cornblatt BA;
    Arch Gen Psychiatry; 2010 Jun; 67(6):578-88. PubMed ID: 20530007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting psychosis risk using a specific measure of cognitive control: a 12-month longitudinal study.
    Guo JY; Niendam TA; Auther AM; Carrión RE; Cornblatt BA; Ragland JD; Adelsheim S; Calkins R; Sale TG; Taylor SF; McFarlane WR; Carter CS
    Psychol Med; 2020 Oct; 50(13):2230-2239. PubMed ID: 31507256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated cortical thinning precedes and predicts conversion to psychosis: The NAPLS3 longitudinal study of youth at clinical high-risk.
    Collins MA; Ji JL; Chung Y; Lympus CA; Afriyie-Agyemang Y; Addington JM; Goodyear BG; Bearden CE; Cadenhead KS; Mirzakhanian H; Tsuang MT; Cornblatt BA; Carrión RE; Keshavan M; Stone WS; Mathalon DH; Perkins DO; Walker EF; Woods SW; Powers AR; Anticevic A; Cannon TD
    Mol Psychiatry; 2023 Mar; 28(3):1182-1189. PubMed ID: 36434057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognition in clinical high risk young adults who did or did not convert to a first schizophrenic psychosis: a meta-analysis.
    De Herdt A; Wampers M; Vancampfort D; De Hert M; Vanhees L; Demunter H; Van Bouwel L; Brunner E; Probst M
    Schizophr Res; 2013 Sep; 149(1-3):48-55. PubMed ID: 23830855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up.
    Lunsford-Avery JR; Gonçalves BDSB; Brietzke E; Bressan RA; Gadelha A; Auerbach RP; Mittal VA
    Schizophr Res; 2017 Nov; 189():37-42. PubMed ID: 28169087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of psychosis in prodrome: development and validation of a simple, personalized risk calculator.
    Zhang T; Xu L; Tang Y; Li H; Tang X; Cui H; Wei Y; Wang Y; Hu Q; Liu X; Li C; Lu Z; McCarley RW; Seidman LJ; Wang J;
    Psychol Med; 2019 Sep; 49(12):1990-1998. PubMed ID: 30213278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
    Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
    JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
    Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
    Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and extracellular white matter alterations indicate conversion to psychosis among individuals at clinical high-risk for psychosis.
    Nägele FL; Pasternak O; Bitzan LV; Mußmann M; Rauh J; Kubicki M; Leicht G; Shenton ME; Lyall AE; Mulert C
    World J Biol Psychiatry; 2021 Mar; 22(3):214-227. PubMed ID: 32643526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis.
    ; Jalbrzikowski M; Hayes RA; Wood SJ; Nordholm D; Zhou JH; Fusar-Poli P; Uhlhaas PJ; Takahashi T; Sugranyes G; Kwak YB; Mathalon DH; Katagiri N; Hooker CI; Smigielski L; Colibazzi T; Via E; Tang J; Koike S; Rasser PE; Michel C; Lebedeva I; Hegelstad WTV; de la Fuente-Sandoval C; Waltz JA; Mizrahi R; Corcoran CM; Resch F; Tamnes CK; Haas SS; Lemmers-Jansen ILJ; Agartz I; Allen P; Amminger GP; Andreassen OA; Atkinson K; Bachman P; Baeza I; Baldwin H; Bartholomeusz CF; Borgwardt S; Catalano S; Chee MWL; Chen X; Cho KIK; Cooper RE; Cropley VL; Dolz M; Ebdrup BH; Fortea A; Glenthøj LB; Glenthøj BY; de Haan L; Hamilton HK; Harris MA; Haut KM; He Y; Heekeren K; Heinz A; Hubl D; Hwang WJ; Kaess M; Kasai K; Kim M; Kindler J; Klaunig MJ; Koppel A; Kristensen TD; Kwon JS; Lawrie SM; Lee J; León-Ortiz P; Lin A; Loewy RL; Ma X; McGorry P; McGuire P; Mizuno M; Møller P; Moncada-Habib T; Muñoz-Samons D; Nelson B; Nemoto T; Nordentoft M; Omelchenko MA; Oppedal K; Ouyang L; Pantelis C; Pariente JC; Raghava JM; Reyes-Madrigal F; Roach BJ; Røssberg JI; Rössler W; Salisbury DF; Sasabayashi D; Schall U; Schiffman J; Schlagenhauf F; Schmidt A; Sørensen ME; Suzuki M; Theodoridou A; Tomyshev AS; Tor J; Værnes TG; Velakoulis D; Venegoni GD; Vinogradov S; Wenneberg C; Westlye LT; Yamasue H; Yuan L; Yung AR; van Amelsvoort TAMJ; Turner JA; van Erp TGM; Thompson PM; Hernaus D
    JAMA Psychiatry; 2021 Jul; 78(7):753-766. PubMed ID: 33950164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA Cohort.
    Koutsouleris N; Worthington M; Dwyer DB; Kambeitz-Ilankovic L; Sanfelici R; Fusar-Poli P; Rosen M; Ruhrmann S; Anticevic A; Addington J; Perkins DO; Bearden CE; Cornblatt BA; Cadenhead KS; Mathalon DH; McGlashan T; Seidman L; Tsuang M; Walker EF; Woods SW; Falkai P; Lencer R; Bertolino A; Kambeitz J; Schultze-Lutter F; Meisenzahl E; Salokangas RKR; Hietala J; Brambilla P; Upthegrove R; Borgwardt S; Wood S; Gur RE; McGuire P; Cannon TD
    Biol Psychiatry; 2021 Nov; 90(9):632-642. PubMed ID: 34482951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.